ADMA Biologics
ADMA
ADMA
58 hedge funds and large institutions have $165M invested in ADMA Biologics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
1.33%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
23
Reduced
12
Closed
5
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$27.7M |
| 2 |
CCM
2
Consonance Capital Management
New York
|
$28.2M |
| 3 |
PVI
3
Pura Vida Investments
New York
|
$3.55M |
| 4 |
4
Renaissance Technologies
New York
|
$1.17M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$1.42M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $10K | 1,642 | – | – |
|
|
MAM
52
Meeder Asset Management
Dublin,
Ohio
| $7K | 1,080 | +684 | +173% |
|
53
Group One Trading
Chicago,
Illinois
| $5K | 6,700 | +6,700 | New |
|
|
AG
54
Advisor Group
Phoenix,
Arizona
| $4K | 600 | +300 | +100% |
|
55
Federated Hermes
Pittsburgh,
Pennsylvania
| $2K | 309 | +309 | New |
|
56
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | 134 | – | – |
|
|
WAP
57
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| $1K | 200 | – | – |
|
|
SCM
58
Stonepine Capital Management
Bend,
Oregon
| – | – | -831,731 | Closed |
|
59
Millennium Management
New York
| – | – | -229,416 | Closed |
|
|
SIM
60
Spark Investment Management
New York
| – | – | -37,460 | Closed |
|
|
RJT
61
Raymond James Trust
St. Petersburg,
Florida
| – | – | -17,792 | Closed |
|
|
PIA
62
Piedmont Investment Advisors
Durham,
North Carolina
| – | – | -328 | Closed |
|
|
CFGS
63
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
TRCT
64
Tower Research Capital (TRC)
New York
| $0 | 25 | +25 | New |
|